Telaprevir intermediate preparation method

A technology of telaprevir and intermediates, which is applied in the field of preparation of telaprevir intermediates, can solve the problems of unsuitability for industrial production, difficult reaction control, long route, etc., and achieve simple operation, easy reaction, and optical purity high effect

Inactive Publication Date: 2014-03-26
HUNAN KEYUAN BIO PRODS
View PDF8 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0008] To sum up, the existing preparation method of Cyclopenta[c]pyrrole-1-carboxylic acid, octahydro-, ethyl ester, (1S,3aR,6aS)-, hydrochloride has long route, low yield and difficult reaction control and other shortcomings, not suitable for industrial production

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0045] The preparation method of the telaprevir intermediate of the present embodiment comprises the following steps:

[0046] (1) Synthesis of (3aR,6aS)-1,3a,4,5,6,6a-hexahydrocyclopentapyrrole

[0047] Add 1500g 10wt% sodium hypochlorite solution to a 10L reaction flask, then add 1200mL MTBE, stir well, add (3aR, 6aS) octahydrocyclopentapyrrole 200g (1.33mol), control the temperature at 15±1°C, and react After 2.0 hours, the reaction solution was obtained;

[0048] Then add 10g tetrabutylammonium bromide to the reaction flask, 1000g mass concentration is 25% NaOH aqueous solution, then add the resulting reaction solution, stir and react at 35°C for 12 hours, static layering, then extract 3 times with MTBE, combine MTBE layer;

[0049] (2) Synthesis of (3aR,6aS)-octahydrocyclopentapyrrole-1-sodium sulfate

[0050] In the reaction flask, add 800mL water, then add 140g NaHSO 3 , then add the MTBE layer obtained in step (1), react at 20±1°C for 2.0 hours, static layering, th...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a telaprevir intermediate preparation method. The telaprevir intermediate preparation method comprises the following steps: (1) synthesizing (3aR, 6aS)-1,3a,4,5,6,6a-hexahydrocyclopentapyrrol; (2) synthesizing (3aR, 6aS)-octahydrocyclopentapyrrol-1-sodium sulfate; (3) synthesizing (3aR, 6aS)- octahydrocyclopentapyrrol-1-cyanogen; (4) synthesizing (3aR, 6aS)- octahydrocyclopentapyrrol-1-carboxylic acid; (5) synthesizing (3aR, 6aS)-2-Boc octahydrocyclopentapyrrol-1-carboxylic acid; (6) synthesizing (1s, 3aR, 6aS)-2-Boc octahydrocyclopentapyrrol-1-carboxylic acid; (7) synthesizing (1s, 3aR, 6aS)-2-Boc octahydrocyclopentapyrrol-1-carboxylic acid ethyl ester salt. The telaprevir intermediate preparation method is reasonable in process, low in cost and simple and convenient to operate, reagents are inexpensive and easy to obtain, and the control on reaction is easy.

Description

technical field [0001] The invention relates to a preparation method of a telaprevir intermediate. Background technique [0002] Telaprevir (Telaprevir, structural formula shown below) has three chiral centers, chemical name (1S,3aR,6aS)-2-((S)-2-((S)-2--2-( pyrazine-2-carboxamido)acetamido)-3,3-dimethylbutanoyl)-N-((S)-1-(cyclopropylamino)-1,2-dioxohexan-3-yl)-octahydrocyclopenta[c]pyrrole-1-carboxamide( telaprevir). Telaprevir (VX-950) is a new drug developed by Vertex Pharmaceuticals of the United States for the treatment of hepatitis C. It was approved by the FDA on May 23, 2011, and its trade name is Incivek. The drug is an oral tablet, which is a reversible protease inhibitor, used in combination with pegylated α-interferon and ribavirin, can effectively inhibit the replication of HVC virus, and is used for chronic hepatitis C. It has a good clinical application prospect. [0003] Its structural formula: [0004] . [0005] The side chain of telaprevir structur...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07D209/52
CPCC07D209/52
Inventor 蔡春林
Owner HUNAN KEYUAN BIO PRODS
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap